Mandy Du
Education
Ph.D., biostatistics, Boston University; M.S., biostatistics, Yale University; B.S., applied mathematics, and B.A., psychology, University of California, San Diego
Summary of Experience
Dr. Du is experienced in developing and applying novel statistical methods in the field of health economics and outcomes research (HEOR). She has a wide range of experience developing and guiding the implementation of analytic study cycles, including claims data analysis, chart review, clinical trial analysis, cost-effectiveness analysis, and indirect treatment comparison. Her work covers a broad range of disease areas such as oncology, hematology, immunology, psychiatry, and women’s health. Dr. Du’s work has been published in peer-reviewed clinical and health economics journals and presented at clinical and economic research conferences.
-
Clinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis
Current Medical Research and Opinion, 2026
2026Smith AG, Habib AA, Qi CZ, Yang H, Du M, Chen X, Heerlein K, Gelinas D, Phillips G, Wolfe GI
-
Healthcare resource utilization and costs in pediatric patients under 6 years old with atopic dermatitis in the United States: A retrospective, observational, cross-sectional study
JAAD International, 2026
2026Silverberg JI, Martins B, Du M, Yang M, Noonan K, Korotzer A, Wang Z
-
Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer
Advances in Therapy, 2025
2025Shah MV, Solem CT, Bell KF, Aziez A, Sun X, Du M, Du EX, Yang H, Wang H, Hua Q, Tapan U
-
Body weight distribution of US patients with myasthenia gravis
Journal of Medical Economics, 2025
2025 -
Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis
Advances in Therapy, October 2024
2024Smith AG, Wolfe GI, Habib AA, Qi CZ, Yang H, Du M, Chen X, Gelinas D, Brauer E, Phillips G, Saccà F
-
March 10, 2025
-
October 29, 2024
-
April 11, 2024